Medifast (NYSE:MED) Director Parsa Kiai Buys 43,150 Shares of Stock

Medifast Inc (NYSE:MED) Director Parsa Kiai bought 43,150 shares of the business’s stock in a transaction that occurred on Thursday, August 20th. The shares were bought at an average price of $11.60 per share, with a total value of $500,540.00. Following the transaction, the director directly owned 661,306 shares in the company, valued at $7,671,149.60. This trade represents a 6.98% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Parsa Kiai also recently made the following trade(s):

• On Wednesday, August 19th, Parsa Kiai purchased 29,337 shares of Medifast stock. The stock was bought at an average price of $11.66 per share, for a total transaction of $342,069.42.

Medifast Stock Up 2.2%

Medifast stock traded up $0.25 during mid-day trading on Friday, hitting $11.87. 54,923 shares of the company were exchanged, compared to its average volume of 231,125. The company has a market capitalization of $132.71 million, a PE ratio of -5.09 and a beta of 0.65. The business has a fifty day moving average of $10.92 and a 200 day moving average of $11.06. Medifast Inc has a 1-year low of $9.22 and a 1-year high of $14.67.

Medifast (NYSE:MED) last issued its earnings results on Monday, August 3rd. The specialty retailer reported ($0.28) EPS for the quarter, beating the consensus estimate of ($0.65) by $0.37. Medifast had a negative net margin of 8.08% and a negative return on equity of 6.69%. The company had revenue of $76.38 million for the quarter, compared to the consensus estimate of $72.70 million. Medifast has set its FY 2026 guidance at -1.750–0.250 EPS and its Q3 2026 guidance at -0.650–0.150 EPS. Research analysts expect that Medifast Inc will post -1 earnings per share for the current year.

Analysts Set New Price Targets

MED has been the subject of several recent analyst reports. Weiss Ratings raised shares of Medifast from a “sell (e+)” rating to a “sell (d)” rating in a report on Monday. Zacks Research downgraded Medifast from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Two research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $12.00.

Institutional Investors Weigh In On Medifast

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets raised its stake in shares of Medifast by 103.1% in the third quarter. BNP Paribas Financial Markets now owns 2,338 shares of the specialty retailer’s stock worth $32,000 after acquiring an additional 1,187 shares during the last quarter. Quantbot Technologies LP bought a new position in Medifast in the 3rd quarter worth approximately $37,000. Intesa Sanpaolo Wealth Management acquired a new position in Medifast during the 4th quarter worth $47,000. State of Wyoming acquired a new position in Medifast during the 4th quarter worth $59,000. Finally, Strs Ohio bought a new position in Medifast in the 1st quarter valued at $78,000. Institutional investors and hedge funds own 95.51% of the company’s stock.

Medifast Company Profile

Medifast, Inc (NYSE: MED) is a health and wellness company specializing in clinically supported weight-loss, weight-management and healthy living products and services. Through its OPTAVIA brand, the company offers a range of meal replacement products, snacks, supplements and coaching programs designed to support metabolic health and sustainable lifestyle changes. Medifast markets its products directly to consumers via a network of independent distributors—known as OPTAVIA Coaches—who provide personalized guidance and support throughout the client’s weight?loss journey.

Founded in 1980 by William Vitale and headquartered in Baltimore, Maryland, Medifast has grown into a nationally recognized provider of nutrition and weight?management solutions.